Yellow Fever
Yellow fever is a viral disease transmitted by mosquitoes causing a spectrum of disease from mild to severe symptoms Yellow fever (YF) is a vaccine preventable viral infection transmitted predominantly by certain species of day biting mosquitoes. YF virus can cause an illness that results in jaundice (yellowing of the skin and eyes) and bleeding, with severe damage to the major organs. The death rate is high in those who develop severe disease.
YF is a risk in parts of the tropical and sub-tropical regions of Africa and South and Central America and in Trinidad (Caribbean). Areas with a risk of YF transmission are countries (or areas within countries) where mosquito species known to transmit the disease are present and where the infection is reported in monkeys and/or humans. Yellow fever is rare in western travellers. The last reported case in the UK was acquired by a laboratory technician working with the virus in London in the 1930s. 
Prevention
Those visiting YF risk areas should practise meticulous mosquito bite avoidance. People who had incidental removal of their thymus after the age of one year may therefore receive a yellow fever vaccine following a detailed risk assessment. A cautious approach is recommended for those who had incidental removal of their thymus before the age of one year. In these cases further advice should be sought.
Yellow fever vaccine

Precautions
For those with a febrile illness (fever) or who are acutely unwell, YF vaccination should be postponed until full recovery.
Where travel to YF risk areas is unavoidable, YF vaccination may be considered for the following groups (expert opinion may be advisable, see resources below for details on adverse events):
Breast feeding women Infants age six to eight months Individuals age 60 years and older HIV-infected individuals (with a CD4 count greater than 200 and a suppressed viral load, specialist advice should be sought) Pregnant women
With some exceptions, protection from YF vaccination lasts for at least 35 years, and could be lifelong. Reinforcing immunisation (booster dose) should be offered to a small subset of travellers who may be at continued risk see Public Health England guidance.
As of 11 July 2016, The World Health Organization states that the period of validity of the yellow fever certificate (ICVP) has changed from 10 years to the duration of the life of the person vaccinated. This applies to all ICVPs for yellow fever vaccination, including certificates already issued, and new or duplicate certificates.
Individual country certificate requirements should be checked on our Country Information pages.
Resources
More detailed information can be found in our Yellow fever factsheet. Public Health England: Immunisation against infectious disease. Yellow fever. Further details on yellow fever vaccine can be found on the Summary of Product Characteristics (SPC) on the electronic Medicines Compendium Yellow fever information leaflet for travellers
